Chinese medicine to regulate immunity
Conditions
Interventions
Control group:Nothing
Medication group:Each dose of the above formula is prepared as two sachets of granules and the two sachets of granules are divided into two times.
Sponsors
Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. Participants must be aged 18–40 years and meet diagnostic criteria for healthy individuals; 2. Received COVID-19 vaccination between December 1, 2022, and March 1, 2023; 3. Signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Subjects taking other medications concurrently with the study drug; 2. Pregnant or lactating women; 3. Alcohol abuse; 4. Impaired gastrointestinal function, malabsorption syndrome, active peptic ulcer; 5. Undergone surgery within 4 weeks prior to study drug administration or currently having open wounds; 6. Received any investigational drug within 4 weeks prior to first administration of the study drug; 7. Experienced acute infections within 4 weeks, such as respiratory tract infections, gastrointestinal infections, or periodontitis; 8. Subjects unable to comply with study requirements.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Proportion of T cells; | — |
Primary
| Measure | Time frame |
|---|---|
| Proportion of B cells;Proportion of antigenic RBD-specific B cells; | — |
Countries
China
Contacts
Public ContactLin Miao
Tianjin University of Traditional Chinese Medicine
Outcome results
None listed